Related references
Note: Only part of the references are listed.LncRNA ABHD11-AS1 Participates in the Progression of Cervical Carcinoma by Targeting miR-1254 and Is the Key to the Diagnosis and Treatment of Cervical Carcinoma in the Future
Duanrong Zhu et al.
JOURNAL OF HEALTHCARE ENGINEERING (2022)
Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
Wei-Chun Chen et al.
BIOMEDICAL JOURNAL (2022)
Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer
Victor M. Schuettfort et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Quercetin suppresses cell survival and invasion in oral squamous cell carcinoma via the miR-1254/CD36 cascade in vitro
L. Chen et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2021)
Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets
Loris De Cecco et al.
CANCERS (2021)
Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer
Akanksha Khandelwal et al.
FRONTIERS IN ONCOLOGY (2021)
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
Elizabeth Fraley et al.
BMC MEDICINE (2021)
Inhibition of miR-483-5p improves the proliferation, invasion and inflammatory response of triple-negative breast cancer cells by targeting SOCS3
Jianbo Ren et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue
Yahui Jiang et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer
Jiefei Peng et al.
BIOMATERIALS SCIENCE (2021)
Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5
Xu Lu et al.
JOURNAL OF CANCER (2021)
Inhibition of miR-574-5p suppresses cell growth and metastasis and enhances chemosensitivity by targeting RNA binding protein QKI in cervical cancer cells
Rui Tong et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis
Chaoyang Sun et al.
ONCOGENE (2020)
miR-1254 inhibits progression of glioma in vivo and in vitro by targeting CSF-1
Xin Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer
Ludek Zavesky et al.
REPRODUCTIVE SCIENCES (2019)
Ovarian Cancer: Differentially Expressed microRNAs in Tumor Tissue and Cell-Free Ascitic Fluid as Potential Novel Biomarkers
Ludek Zavesky et al.
CANCER INVESTIGATION (2019)
MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation
Yong-Shuang Li et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer
Mingkun Jiang et al.
CELL DEATH & DISEASE (2019)
Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer
Emelie Radestad et al.
ONCOIMMUNOLOGY (2019)
Long Noncoding RNA LINC01125 Enhances Cisplatin Sensitivity of Ovarian Cancer via miR-1972
Jia Guo et al.
MEDICAL SCIENCE MONITOR (2019)
MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2
Hui Hui Xie et al.
BIOLOGICAL RESEARCH (2019)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells
Marianna Gallo et al.
Oncotarget (2018)
A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer
Tao Zhu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples
Ovidiu-Leonard Braicu et al.
ONCOTARGETS AND THERAPY (2017)
TIMPs: versatile extracellular regulators in cancer
Hartland W. Jackson et al.
NATURE REVIEWS CANCER (2017)
The clinical significance of vascular endothelial growth factor in malignant ascites
Na Zhan et al.
TUMOR BIOLOGY (2016)
Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer
Guangcun Cheng et al.
MOLECULAR CANCER (2016)
Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites
Byungho Lim et al.
ONCOTARGET (2016)
Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-alpha and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer
Nonna Kolomeyevskaya et al.
GYNECOLOGIC ONCOLOGY (2015)
MiR-320a contributes to atherogenesis by augmenting multiple risk factors and down-regulating SRF
Chen Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
The biological functions of miRNAs: lessons from in vivo studies
Joana A. Vidigal et al.
TRENDS IN CELL BIOLOGY (2015)
Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
J. Kumar et al.
BRITISH JOURNAL OF CANCER (2014)
Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
I. Shapira et al.
BRITISH JOURNAL OF CANCER (2014)
miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM
Qiancheng Song et al.
CANCER RESEARCH (2014)
Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion
Hye-Suk Han et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer
Takeshi Chiyomaru et al.
PLOS ONE (2013)
TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression
Yixuan Gong et al.
PLOS ONE (2013)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses
Yu-Li Chen et al.
PLOS ONE (2012)
Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
Karina Dahl Steffensen et al.
BMC CANCER (2010)
MicroRNAs in ovarian cancer biology and therapy resistance
Marijn T. M. van Jaarsveld et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Chemotherapy Induces Macrophage Chemoattractant Protein-1 Production in Ovarian Cancer
Melissa A. Geller et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Roles of small RNAs in tumor formation
Gianpiero Di Leva et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Pattern and prognostic factors in patients with malignant ascites: a retrospective study
A. A. Ayantunde et al.
ANNALS OF ONCOLOGY (2007)
Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder
Sami Tsukishiro et al.
GYNECOLOGIC ONCOLOGY (2006)
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling
B Davidson et al.
CLINICAL CANCER RESEARCH (2006)
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma
R Eitan et al.
CANCER (2005)
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies -: Possible involvement of regulatory T cells in disease progression
T Sasada et al.
CANCER (2003)
Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer
LJ Havrilesky et al.
GYNECOLOGIC ONCOLOGY (2003)
Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer
B Andrews et al.
JOURNAL OF UROLOGY (2002)
The role of angiogenesis in the accumulation of peritoneal fluid in benign conditions and the development of malignant ascites in the female
DM Sherer et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2000)
Share Paper
